Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI

Contrast Media and Molecular Imaging

Volumn 5, Issue 5, 2010, Pages 268-275

  Von Zur Muhlen, C ^a   Fink Petri, A ^b   Salaklang, J ^b   Paul, D ^a   Neudorfer, I ^a   Berti, V ^a   Merkle, A ^a   Peter, K ^c   Bode, C ^a   Von Elverfeldt, D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

atherosclerosis; inflammation; magnetic resonance imaging; monocytes

Indexed keywords

APOLIPOPROTEIN E; CD11B ANTIGEN; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL LABELING; CONTROLLED STUDY; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOLECULAR IMAGING; MONOCYTE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN TARGETING; SUBCLAVIAN ARTERY;

ANIMALS; ANTIGENS, CD11B; APOLIPOPROTEINS E; CELLS, CULTURED; CONTRAST MEDIA; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; MONOCYTES; NANOPARTICLES; PLAQUE, ATHEROSCLEROTIC;

EID: 78349295340     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.384     Document Type: Article

References (28)

1. Corti R, Farkouh ME, Badimon JJ,. The vulnerable plaque and acute coronary syndromes. Am J Med 2002; 113 (8): 668 - 680.
2. Hansson GK,. Inflammation, atherosclerosis, and coronary artery disease. New Engl J Med 2005; 352 (16): 1685 - 1695.
3. Choudhury RP, Fisher EA,. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol 2009; 29 (7): 983 - 991.
4. Choudhury RP, Fuster V, Fayad ZA,. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 2004; 3 (11): 913 - 925.
5. Trivedi RA, UK-I JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, Skepper JN, Quartey G, Warburton E, Joubert I, Wang L, Kirkpatrick PJ, Brown J, Gillard JH,. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004; 35 (7): 1631 - 1635.
6. Trivedi RA, Mallawarachi C, UK-I JM, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang L, Kirkpatrick PJ, Brown J, Gillard JH,. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006; 26 (7): 1601 - 1606.
7. Ruehm SG, Corot C, Vogt P, Cristina H, Debatin JF,. Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits. Acad Radiol. 2002; 9 (suppl 1): S143 - S144.
8. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM,. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107 (19): 2453 - 2458.
9. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F,. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24 (6): 1001 - 1011.
10. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M,. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation 2003; 107 (11): 1545 - 1549.
11. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C,. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004; 39 (1): 56 - 63.
12. von Zur Muhlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink A, Hofmann H, Bode C, Peter K,. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007; 193 (1): 102 - 111.
13. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA,. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA 2007; 104 (3): 961 - 966.
14. Coleman R, Hayek T, Keidar S, Aviram M,. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta Histochem 2006; 108 (6): 415 - 424.
15. Kanse SM, Matz RL, Preissner KT, Peter K,. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18). Arterioscler Thromb Vasc Biol 2004; 24 (12): 2251 - 2256.
16. Schuler P, Assefa D, Ylanne J, Basler N, Olschewski M, Ahrens I, Nordt T, Bode C, Peter K,. Adhesion of monocytes to medical steel as used for vascular stents is mediated by the integrin receptor Mac-1 (CD11b/CD18; alphaM beta2) and can be inhibited by semiconductor coating. Cell Commun Adhes 2003; 10 (1): 17 - 26.
17. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Shibata T, Sato K, Iguchi A,. A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26 (6): 1304 - 1309.
18. Calara F, Silvestre M, Casanada F, Yuan N, Napoli C, Palinski W,. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 2001; 195 (2): 257 - 263.
19. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ,. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117 (1): 185 - 194.
20. Swirski FK, Weissleder R, Pittet MJ,. Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29 (10): 1424 - 1432.
21. Bremicker J, Klug G, Kampf T, Bauer E, Basse-Lüsebrink T, Weber M, Gbureck U, Nöth U, Jakob P, Bauer WR,. Detection limits of very small iron oxide nanoparticles in labeled cells: a quantitative evaluation of histochemistry and MR-relaxometry. German Cardiac Society 2009; abstract supplement, annual meeting.
22. Chastellain M, Petri A, Hofmann H,. Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J Colloid Interface Sci 2004; 278 (2): 353 - 360.
23. Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H,. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 2005; 26 (15): 2685 - 2694.
24. Skkog DA,. Fundamentals of Analytical Chemistry. Harcourt College: Fort Worth, TX, 1996.
25. Steitz B, Salaklang J, Finka A, O'Neil C, Hofmann H, Petri-Fink A,. Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles. Bioconjug Chem 2007; 18 (5): 1684 - 1690.
26. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40 (11): 715 - 724.
27. Stalder AF, Elverfeldt DV, Paul D, Hennig J, Markl M,. Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T. Magn Reson Med. 2008; 59 (1): 113 - 123.
28. Coleman R, Hayek T, Keidar S, Aviram M,. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta Histochem 2006; 108 (6): 415 - 424.